BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 22895265)

  • 1. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
    Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
    Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
    Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
    Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosome.
    Shon W; Peters MS; Reed KB; Ketterling RP; Dogan A; Gibson LE
    J Cutan Pathol; 2013 Aug; 40(8):725-9. PubMed ID: 23639193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
    Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
    J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
    Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
    Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
    Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
    Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic Indeterminate Dendritic Cell Tumor Associated With Chronic Myelomonocytic Leukemia.
    Ellis A; Elbaz Younes I; Shao H; Zhang X
    Am J Dermatopathol; 2022 Sep; 44(9):691-695. PubMed ID: 35476037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Indeterminate Cutaneous Dendritic Cell Tumors in the Setting of Chronic Myelomonocytic Leukemia.
    Nyckowski T; Vance P; Marks E
    Am J Dermatopathol; 2022 Jun; 44(6):449-453. PubMed ID: 35385851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.
    Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C
    Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
    Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnostic specific skin infiltrates in chronic myelomonocytic leukemia].
    Federmann B; Metzler G; Bonzheim I; Fend F
    Pathologe; 2015 Sep; 36(5):494-7. PubMed ID: 26292933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report.
    Li JJ; Talam S; Star P; Getta B
    J Cutan Pathol; 2021 May; 48(5):680-688. PubMed ID: 33416192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review.
    Espasa A; Sorigue M; Tapia G; Cabezon M; Vergara S; Raya M; Navarro JT; Junca J; Zamora L; Xicoy B
    Cytometry B Clin Cytom; 2021 May; 100(3):292-295. PubMed ID: 32830878
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.
    Rollins-Raval MA; Roth CG
    Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.
    Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K
    J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.